A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neutropenia in Breast Cancer
Interventions: DRUG: Filgrastim (Eurofarma)|DRUG: Filgrastim (Granulokine, Amgen)
Sponsor: Eurofarma Laboratorios S.A.